Publication
Metastatic organotropism: a brief overview
| dc.contributor.author | Carrolo, M | |
| dc.contributor.author | Miranda, JA | |
| dc.contributor.author | Vilhais, G | |
| dc.contributor.author | Quintela, A | |
| dc.contributor.author | Fontes e Sousa, M | |
| dc.contributor.author | Alpuim-Costa, D | |
| dc.contributor.author | Pinto, FR | |
| dc.date.accessioned | 2024-05-19T20:48:43Z | |
| dc.date.available | 2024-05-19T20:48:43Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | Organotropism has been known since 1889, yet this vital component of metastasis has predominantly stayed elusive. This mini-review gives an overview of the current understanding of the underlying mechanisms of organotropism and metastases development by focusing on the formation of the pre-metastatic niche, immune defenses against metastases, and genomic alterations associated with organotropism. The particular case of brain metastases is also addressed, as well as the impact of organotropism in cancer therapy. The limited comprehension of the factors behind organotropism underscores the necessity for efficient strategies and treatments to manage metastases. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Front Oncol . 2024 Apr 25:14:1358786. | pt_PT |
| dc.identifier.doi | 10.3389/fonc.2024.1358786 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.26/50855 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.subject | Neoplasias | pt_PT |
| dc.subject | Microambiente Tumoral | pt_PT |
| dc.subject | Neoplasms | pt_PT |
| dc.subject | Tumor Microenvironment | pt_PT |
| dc.title | Metastatic organotropism: a brief overview | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.title | Frontiers in Oncology | pt_PT |
| oaire.citation.volume | 14 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |